David Bradley

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Association Between Specific Adipose Tissue CD4+ T-Cell Populations and Insulin Resistance in Obese Individuals

Elisa Fabbrini, Marina Cella, Anja Fuchs et al. · Gastroenterology · 2013 · 276 citations · Full text

Life Sciences, Immunology, Physiology +14

Weight Loss Induced by Roux-en-Y Gastric Bypass But Not Laparoscopic Adjustable Gastric Banding Increases Circulating Bile Acids

Rohit Kohli, David Bradley, Kenneth D.R. Setchell et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 267 citations · Full text

Medicine, Endocrinology, Surgery +17

Gastric bypass and banding equally improve insulin sensitivity and β cell function

David Bradley, Caterina Conte, Bettina Mittendorfer et al. · Journal of Clinical Investigation · 2012 · 247 citations · Full text

Medicine, Endocrinology, Surgery +17